Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial

MLA

Ashish Bavdekar, et al. “Immunogenicity and Safety of a New Meningococcal A Conjugate Vaccine in Indian Children Aged 2-10 Years: A Phase II/III Double-Blind Randomized Controlled Trial.” Vaccine, vol. 30, no. 45, Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1c84babb533293c274c9fa733fa7361&authtype=sso&custid=ns315887.

APA

Ashish Bavdekar, Yuxiao Tang, Prasad S. Kulkarni, Elisa Marchetti, Brian D. Plikaytis, George M. Carlone, Varsha Parulekar, Siddhivinayak Hirve, Sanjay Juvekar, Akshay Goel, Marie-Pierre Préziosi, Subhash V. Kapre, Karupothula Suresh, Jean-Marie Preaud, Ray Borrow, Simonetta Viviani, Suresh Jadhav, Helen Findlow, F. Marc LaForce, … Anand Pandit. (2012). Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial. Vaccine, 30(45).

Chicago

Ashish Bavdekar, Yuxiao Tang, Prasad S. Kulkarni, Elisa Marchetti, Brian D. Plikaytis, George M. Carlone, Varsha Parulekar, et al. 2012. “Immunogenicity and Safety of a New Meningococcal A Conjugate Vaccine in Indian Children Aged 2-10 Years: A Phase II/III Double-Blind Randomized Controlled Trial.” Vaccine 30 (45). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b1c84babb533293c274c9fa733fa7361&authtype=sso&custid=ns315887.